Skip to main content
Clinical Trials/NL-OMON36533
NL-OMON36533
Not yet recruiting
Not Applicable

Diagnostic Accuracy of an Electronic Nose as Compared to Combined Conventional CT-Scanning, Autofluorescense Scopy for the Detection of Early Endobronchial Squamous Cell Cancer after prior History of Head-and-neck Cancer or Lung Cancer - New Techniques ENT

Academisch Medisch Centrum0 sites315 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Early Endobronchial Squamous Cell Cancer
Sponsor
Academisch Medisch Centrum
Enrollment
315
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \* Patients who received a curative treatment for head\-and\-neck or lung cancer, including all tumour stages.
  • \* Curative treatment \> 1year ago
  • \* Smoker or ex\-smoker
  • \* Age \> 18
  • \* Written informed consent.

Exclusion Criteria

  • \* Residual cancer or recurrence at the time of screening with standard screening methods.
  • \* Contraindications to bronchoscopy, as noted in the Dutch consensus guideline \*bronchoscopy\* (2003\)
  • \* Prior bronchoscopy with local treatment in the preceding two years.
  • \* Serious non\-malignant disease (e.g., congestive heart failure, or active uncontrolled bacterial, viral, or fungal infections) or other conditions that, in the opinion of the investigator, would compromise study objectives.
  • \* Uncontrollable bleeding tendency.

Outcomes

Primary Outcomes

Not specified

Similar Trials